Status:
COMPLETED
LILLE COVID RESEARCH NETWORK (Covid-19)
Lead Sponsor:
University Hospital, Lille
Conditions:
Sars-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
The Lille University Hospital developped a research objective common to all the services which took care of patients, "suspected patient", "possible case", "probable case" or "confirmed case" infected...
Detailed Description
This is a retrospective and prospective observational monocentric cohort study designed to identify predictors of mortality on day 28 in patients treated at the Lille University Hospital for COVID-19.
Eligibility Criteria
Inclusion
- All adult "suspect patient", "possible case", "probable case" or "confirmed case" of an SARS-CoV-2 infection admitted to Lille University Hospital.
Exclusion
- Minor patient Patient under guardianship or curatorship Refusal to participate in the study Patient for whom the collection of genetic non-opposition or consent is impossible because of a language barrier with the patient himself or herself or with his or her trusted person or close family.
- Patient for whom the collection of genetic non-opposition or consent is impossible because of his or her state of health at the time of inclusion in the study and for whom the trusted person or close family member opposes participation in the study.
- Translated with www.DeepL.com/Translator (free version)
Key Trial Info
Start Date :
August 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
757 Patients enrolled
Trial Details
Trial ID
NCT04475211
Start Date
August 10 2020
End Date
June 15 2022
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Claude Huriez Chr Lille
Lille, France, 59037